Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
5.15 EUR
6.4%
Market Closed
Updated:
Apr 27, 2024
Vita 34 AG
Cash from Investing Activities
|
Vita 34 AG
Cash from Investing Activities Peer Comparison
Comparables:
F
FME
F
FRE
E
1846
SYAB
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Cash from Investing Activities
-€4.3m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-18%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Cash from Investing Activities
-€544.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
5%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Cash from Investing Activities
-€3.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
1%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Cash from Investing Activities
-HK$131.8m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Cash from Investing Activities
€144.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Cash from Investing Activities?
Cash from Investing Activities
-4.3m
EUR
-4.3m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Cash from Investing Activities amounts to -4.3m EUR.
What is Vita 34 AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-18%
-18%
The average annual Cash from Investing Activities growth rates for Vita 34 AG have been -75% over the past three years , 3% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
